Welcome to LookChem.com Sign In|Join Free

CAS

  • or

247186-50-1

Post Buying Request

247186-50-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

247186-50-1 Usage

General Description

TERT-BUTYL 3-BENZYLOXY-4-BROMOBENZOATE is a synthetic compound with a complex chemical structure. It is a derivative of benzoic acid and contains a tert-butyl group, a benzyl ether group, and a bromine atom attached to a benzene ring. TERT-BUTYL 3-BENZYLOXY-4-BROMOBENZOATE is commonly used in organic synthesis and pharmaceutical research as a reagent or intermediate for the production of various chemical compounds. Its specific chemical properties and potential applications are of interest to researchers in the fields of medicinal chemistry and drug development.

Check Digit Verification of cas no

The CAS Registry Mumber 247186-50-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,7,1,8 and 6 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 247186-50:
(8*2)+(7*4)+(6*7)+(5*1)+(4*8)+(3*6)+(2*5)+(1*0)=151
151 % 10 = 1
So 247186-50-1 is a valid CAS Registry Number.
InChI:InChI=1/C18H19BrO3/c1-18(2,3)22-17(20)14-9-10-15(19)16(11-14)21-12-13-7-5-4-6-8-13/h4-11H,12H2,1-3H3

247186-50-1Relevant articles and documents

Synthesis and protein kinase inhibitory activity of balanol analogues with modified benzophenone subunits

Lampe, John W.,Jagdmann Jr., G. Erik,Johnson, Mary George,Lai, Yen-Shi,Lowden, Christopher T.,Lynch, Michael P.,Mendoza, José S.,Murphy, Marcia M.,Wilson, Joseph W.,Ballas, Lawrence M.,Carter, Kiyomi,Biggers, Christopher K.,Darges, James W.,Davis, Jefferson E.,Hubbard, Frederick R.,Stamper, Mark L.,Defauw, Jean M.,Foglesong, Robert J.,Hall, Steven E.,Heerding, Julia M.,Hollinshead, Sean P.,Hu, Hong,Hughes, Philip F.

, p. 2624 - 2643 (2007/10/03)

A series of analogues of the protein kinase C (PKC) inhibitory natural product balanol which bear modified benzophenone subunits are described. The analogues were designed with the goal of uncovering structure -activity features that could be used in the development of PKC inhibitors with a reduced polar character compared to balanol itself. The results of these studies suggest that most of the benzophenone features found in the natural product are important for obtaining potent PKC inhibitory compounds. However, several modifications were found to lead to selective inhibitors of the related enzyme protein kinase A (PKA), and several specific modifications to the polar structural elements of the benzophenone were found to provide potent PKC inhibitors. In particular, it was found that replacement of the benzophenone carboxylate with bioisosteric equivalents could lead to potent analogues. Further, a tolerance for lipophilic substituents on the terminal benzophenone ring was uncovered. These results are discussed in light of recently available structural information for PKA.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 247186-50-1